THE BINDING SITE
LIVE

Serial Number

77331874

Owner

THE BINDING SITE GROUP, LTD.

Attorney

Kenya Williams

Filing Date

Nov 16, 2007

Add to watchlist:

No watchlists yet
View on USPTO

THE BINDING SITE Trademark

Serial Number: 77331874 • Registration: 3479719

THE BINDING SITE is a trademark filed by THE BINDING SITE GROUP, LTD. on November 16, 2007. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

THE BINDING SITE GROUP, LTD. (24 trademarks)

P.O. BOX 11712
BIRMINGHAM B14 4ZB , GB

Entity Type: 03

The Binding Site, Ltd. (9 trademarks)

PO Box 11712
Birmingham B144ZB , GB

Entity Type: 03

Trademark Details

Filing Date

November 16, 2007

Registration Date

August 5, 2008

Published for Opposition

May 20, 2008

Goods & Services

Apparatus for testing gas, liquids and solids; and electronic apparatus for electrophysiological measurement and testing of cells; blank magnetic data carriers; computer software for use in data manipulation and instrument control for use in measuring the concentration of proteins, antibodies, antigens and other substances in body fluids for use in the diagnosis, treatment, prevention, cure and mitigation of diseases and other conditions in humans; and nephelometers for use in measuring the concentration of proteins, antibodies, antigens and other substances in body fluids for use in the diagnosis, treatment, prevention, cure and mitigation of diseases and other conditions in humans; electronic and computerized radial immunodiffusion plate readers; electrophoresis tank and power supply, for laboratory use; gel presses for pressing and drying gels; laboratory equipment, namely, incubators

Calibrating solutions, diluents, control samples, reagents, antibodies, antigen substrates, conjugates, stopping solutions, immunofluorescence reagents, histology reagents, enzyme immunoassay reagents and general purpose reagents for medical and veterinary diagnostic and clinical use; and diagnostic and immunological test kits consisting of reagents, controls, buffers, calibrators, diluents, antibodies, antigen substrates, conjugates, stopping solutions, antisera and/or dropper bottles, all for use in measuring the concentration of proteins, antibodies, antigens and other substances in blood, other body fluids and body tissues, or extracts thereof, for use in the diagnosis, treatment, cure, prevention or mitigation of diseases and other conditions in humans and animals; biological and chemical preparations and reagents for medical or veterinary use; Clinical medical reagents; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for medical and veterinary use; Diagnostic reagents for medicinal use; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids; Reagents and media for medical and veterinary diagnostic purposes; Reagents for medical use; medical diagnostic kits for use in electrophoresis, immunology and serology, consisting primarily of extracts from blood or body fluids; control solutions indicative of a positive result for medical use; buffer solutions for diluting samples and/or reagents for medical use; reagents, blood reagents; electrophoretic gels for medical purposes; protein stain, for visualizing results, for medical purposes; antisera for precipitating specific proteins, for medical purposes; fixative for precipitating proteins, for medical purposes; templates for controlling the application of samples and/or antisera, for medical purposes; blotting paper and blotting tissues for removing excess liquid for gels, for medical purposes

Diagnostic kits comprised of diagnostic reagents for laboratory use, calibrators, reagent plates, buffered solutions, diluent solutions, and serum; Reagents, diagnostic reagents, biological reagents, histology reagents, enzyme radioimmunoassay reagents, immunoassay reagents, antigen substrates, and antibodies for scientific research use; and test kits comprised of reagents, buffers, calibrators, diluents, antibodies, antigen substrates, conjugates, stopping solutions, antisera and/or dropper bottles for scientific and research use using blood, body fluids, body tissues or extracts thereof; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Chemicals, namely, buffer and standard solutions used in analytical chemistry; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific use; Diagnostic preparations used in science; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Reagents for chemical analyses; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; electrophoresis gels other than for medical or veterinary purposes

Medical diagnostic apparatus and instruments for the diagnosis, treatment and cure of diseases in humans, namely, multiple myeloma, lymphocytic neoplasms, Waldenstrom's macroglobulinemia, amyloidosis, light chain deposition diseases and connective tissues diseases, namely, systemic lupus erythematosus; apparatus for blood, urine and serum analysis; apparatus for clinical diagnosis; apparatus used in implementing diagnostic tests designed to detect abnormalities in blood, serum and urine, namely, automated clinical analyzers based on colorimetric and turbidmetric measurements, diluents, reagents, calibrators, and control serum; and medical diagnostic apparatus and analytical apparatus for medical purposes

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 12, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 12, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 12, 2025 REAP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 26, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 26, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 26, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 26, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 26, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 26, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 26, 2024 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 15, 2017 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 15, 2017 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 15, 2017 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 15, 2017 APRE
TEAS SECTION 8 & 9 RECEIVED
Aug 7, 2017 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 5, 2017 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 22, 2013 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 22, 2013 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 22, 2013 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Aug 5, 2013 815F
TEAS SECTION 8 & 15 RECEIVED
Aug 5, 2013 E815
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Aug 31, 2011 ASCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 15, 2011 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 15, 2011 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 8, 2009 ASGN
REGISTERED-PRINCIPAL REGISTER
Aug 5, 2008 R.PR
PUBLISHED FOR OPPOSITION
May 20, 2008 PUBO
NOTICE OF PUBLICATION
Apr 30, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 16, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 15, 2008 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 15, 2008 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 15, 2008 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 15, 2008 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 15, 2008 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 15, 2008 GNRN
NON-FINAL ACTION E-MAILED
Apr 15, 2008 GNRT
NON-FINAL ACTION WRITTEN
Apr 15, 2008 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 15, 2008 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 4, 2008 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 27, 2008 PREV
ASSIGNED TO LIE
Mar 27, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 4, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 1, 2008 GNRN
NON-FINAL ACTION E-MAILED
Mar 1, 2008 GNRT
NON-FINAL ACTION WRITTEN
Mar 1, 2008 CNRT
ASSIGNED TO EXAMINER
Mar 1, 2008 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Nov 21, 2007 MDSC
NEW APPLICATION ENTERED
Nov 20, 2007 NWAP